Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases

Men With Inflammatory Bowel Disease

(2020) Muhammad B. Hammami et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study

(2020) Krista F Huybrechts et al.   BMJ-British Medical Journal

Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study

(2020) Heng Fan et al.   BMJ-British Medical Journal

Oral corticosteroids and risk of preterm birth in the California Medicaid Program

(2020) Kristin Palmsten et al.   Journal of Allergy and Clinical Immunology-In Practice

A systematic review of methods for determining cross-sectional active medications using pharmacy databases

(2019) Timothy S. Anderson et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease

(2019) Anne Grosen et al.   GASTROENTEROLOGY

National population‐based estimates for major birth defects, 2010–2014

(2019) Cara T. Mai et al.   Birth Defects Research

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report

(2018) Gary R. Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)

(2018) Maxime Luu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Paternal exposure to antirheumatic drugs—What physicians should know: Review of the literature

(2018) M.C. Micu et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence

(2018) Maria Mouyis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease

(2017) Uma Mahadevan et al.   GASTROENTEROLOGY

Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy

(2017) Lasse Karlsen Eck et al.   OBSTETRICS AND GYNECOLOGY

Paternal use of azathioprine/6-mercaptopurine or methotrexate within 3 months before conception and long-term health outcomes in the offspring—A nationwide cohort study

(2017) S. Friedman et al.   REPRODUCTIVE TOXICOLOGY

Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study

(2017) Rachel W. Winter et al.   REPRODUCTIVE TOXICOLOGY

Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception

(2016) Michael Due Larsen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

(2016) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study

(2016) B M Nørgård et al.   GUT

Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease

(2016) Zane R. Gallinger et al.   Journal of Crohns & Colitis

Validity of maternal and infant outcomes within nationwide Medicaid data

(2014) Kristin Palmsten et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Brief Report: No Excess Risks in Offspring With Paternal Preconception Exposure to Disease-Modifying Antirheumatic Drugs

(2014) Marianne Wallenius et al.   Arthritis & Rheumatology

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study

(2013) C. Weber-Schoendorfer et al.   RHEUMATOLOGY

Inflammatory bowel disease and pregnancy: Lack of knowledge is associated with negative views

(2012) Christian P. Selinger et al.   Journal of Crohns & Colitis

Algorithms to estimate the beginning of pregnancy in administrative databases

(2012) Andrea V. Margulis et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine

(2012) Maria Hoeltzenbein et al.   REPRODUCTIVE TOXICOLOGY

Positive predictive value of computerized records for major congenital malformations

(2007) William O. Cooper et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY